Ligand Pharmaceuticals | LGND - القيمة السوقية





القيمة السوقية تغيير تاريخ
Agenus USD 3.19B 3.06B 2026-08
Amgen USD 209.65B 14.21B 2026-08
Anika Therapeutics USD 139M 3M 2025-12
Arrowhead Research USD 10.84B 664M 2026-08
Baxter International USD 11.01B 2.34B 2026-06
Bristol-Myers Squibb USD 117.66B 6.17B 2026-06
Eli Lilly USD 1.11T 18.32B 2026-08
Enanta Pharmaceuticals USD 122M 98M 2024-12
Enviri Corporation USD 1.45B 423M 2025-12
Gilead Sciences USD 168.68B 11.82B 2026-08
GlaxoSmithKline GBP 80.14B 3.66B 2026-06
Glaxosmithkline GBP 109.29B 9.36B 2026-03
Heron Therapeutics USD 238M 7M 2025-12
Insmed USD 19.68B 3.43B 2026-08
Ionis Pharmaceuticals USD 13.1B 642M 2026-06
Karyopharm Therapeutics USD 221M 95M 2026-08
Ligand Pharmaceuticals USD 5.31B 1.02B 2026-08
MacroGenics USD 184M 82M 2026-03
Merck USD 324.18B 6.81B 2026-08
Pacira USD 1.28B 286M 2026-08
Pfizer USD 153.17B 14.73B 2026-08
Veracyte USD 4.69B 2.12B 2026-06